3'UTR-CDKN2A and CDK4 Germline Variants Are Associated With Susceptibility to Cutaneous Melanoma

In Vivo. 2021 May-Jun;35(3):1529-1536. doi: 10.21873/invivo.12406.

Abstract

Background/aim: Genetic variations of the CDKN2A and CDK4 gene have been associated to melanoma development. In the present study we investigated the potential associations of CDKN2A and CDK4 gene variants in a colombian population diagnosed with melanoma.

Materials and methods: DNA was extracted from whole blood samples from 85 patients diagnosed with cutaneous melanoma and 166 healthy controls. CDKN2A and CDK4 genes were genotyped using a high-resolution melting assay.

Results: A similar distribution of CDKN2A variants 500C>G and 540C>T was found among cases (12% and 31% respectively) and controls (15% and 31% respectively). The CDKN2A variants were present in 36% of acral lentiginous melanoma and 39.47% of lentigo maligna. The haplotype analysis showed an association with susceptibility in the development of melanoma.

Conclusion: The presence of haplotype 500G/540C in males is associated with an increased risk of melanoma in a colombian population, especially in subjects with a family history of cancer.

Keywords: Haplotype; cancer; germline variant; melanoma; susceptibility; variant.

MeSH terms

  • 3' Untranslated Regions
  • Cyclin-Dependent Kinase 4 / genetics
  • Cyclin-Dependent Kinase Inhibitor p16 / genetics
  • Genetic Predisposition to Disease
  • Germ-Line Mutation / genetics
  • Humans
  • Male
  • Melanoma* / epidemiology
  • Melanoma* / genetics
  • Skin Neoplasms* / genetics

Substances

  • 3' Untranslated Regions
  • CDKN2A protein, human
  • Cyclin-Dependent Kinase Inhibitor p16
  • CDK4 protein, human
  • Cyclin-Dependent Kinase 4